Ludovic SAMALIN
Ludovic SAMALIN
CHU Clermont-Ferrand - University of Auvergne
Verified email at chu-clermontferrand.fr
Title
Cited by
Cited by
Year
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
PM Llorca, M Abbar, P Courtet, S Guillaume, S Lancrenon, L Samalin
BMC psychiatry 13 (1), 1-17, 2013
1412013
Residual symptoms and specific functional impairments in euthymic patients with bipolar disorder
L Samalin, I de Chazeron, E Vieta, F Bellivier, PM Llorca
Bipolar disorders 18 (2), 164-173, 2016
652016
Mood stabilizers and antipsychotics during breastfeeding: focus on bipolar disorder
I Pacchiarotti, J León-Caballero, A Murru, N Verdolini, MA Furio, ...
European Neuropsychopharmacology 26 (10), 1562-1578, 2016
592016
Residual depressive symptoms, sleep disturbance and perceived cognitive impairment as determinants of functioning in patients with bipolar disorder
L Samalin, L Boyer, A Murru, I Pacchiarotti, M Reinares, CM Bonnin, ...
Journal of affective disorders 210, 280-286, 2017
472017
Clinical potential of lurasidone in the management of schizophrenia
L Samalin, M Garnier, PM Llorca
Therapeutics and clinical risk management 7, 239, 2011
462011
Atypical antipsychotic-induced mania/hypomania: a review of recent case reports and clinical studies
A Benyamina, L Samalin
International journal of psychiatry in clinical practice 16 (1), 2-7, 2012
352012
Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines
N Verdolini, D Hidalgo‐Mazzei, A Murru, I Pacchiarotti, L Samalin, ...
Acta Psychiatrica Scandinavica 138 (3), 196-222, 2018
342018
Cost effectiveness of paliperidone long-acting injectable versus other antipsychotics for the maintenance treatment of schizophrenia in France
S Druais, A Doutriaux, M Cognet, A Godet, C Lançon, P Levy, L Samalin, ...
Pharmacoeconomics 34 (4), 363-391, 2016
342016
Potential serotonergic agents for the treatment of schizophrenia
RP Garay, M Bourin, E de Paillette, L Samalin, A Hameg, PM Llorca
Expert opinion on investigational drugs 25 (2), 159-170, 2016
342016
Residual symptoms and functional performance in a large sample of euthymic bipolar patients in France (the OPTHYMUM study)
L Samalin, PM Llorca, B Giordana, V Milhiet, L Yon, W El-Hage, P Courtet, ...
Journal of affective disorders 159, 94-102, 2014
342014
Clinicians’ attitudes toward the use of long-acting injectable antipsychotics
L Samalin, T Charpeaud, O Blanc, S Heres, PM Llorca
The Journal of nervous and mental disease 201 (7), 553-559, 2013
342013
Factors involved in the level of functioning of patients with schizophrenia according to latent variable modeling
PM Llorca, O Blanc, L Samalin, M Bosia, R Cavallaro
European psychiatry 27 (6), 396-400, 2012
342012
Adherence to guidelines by French psychiatrists in their real world of clinical practice
L Samalin, S Guillaume, C Auclair, PM Llorca
The Journal of nervous and mental disease 199 (4), 239-243, 2011
342011
OpenSIMPLe: a real-world implementation feasibility study of a smartphone-based psychoeducation programme for bipolar disorder
D Hidalgo-Mazzei, M Reinares, A Mateu, VL Nikolova, C del Mar Bonnin, ...
Journal of affective disorders 241, 436-445, 2018
332018
Thyroid autoimmunity in bipolar disorder: a systematic review
M Barbuti, AF Carvalho, CA Köhler, A Murru, N Verdolini, G Guiso, ...
Journal of affective disorders 221, 97-106, 2017
332017
Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted …
RP Garay, L Citrome, L Samalin, CC Liu, MS Thomsen, CU Correll, ...
Expert opinion on pharmacotherapy 17 (7), 921-936, 2016
312016
Aggressiveness in depression: a neglected symptom possibly associated with bipolarity and mixed features
N Verdolini, G Perugi, L Samalin, A Murru, J Angst, JM Azorin, ...
Acta Psychiatrica Scandinavica 136 (4), 362-372, 2017
292017
Methodological differences between pharmacological treatment guidelines for bipolar disorder: what to do for the clinicians?
L Samalin, S Guillaume, P Courtet, M Abbar, S Lancrenon, PM Llorca
Comprehensive psychiatry 54 (4), 309-320, 2013
272013
Le sevrage tabagique des «fumeurs difficiles»
J Perriot, M Underner, G Peiffer, J Le Houezec, L Samalin, A Schmitt, ...
Revue des maladies respiratoires 29 (4), 448-461, 2012
272012
Screening and management of bipolar disorders: results
PM Llorca, P Courtet, P Martin, M Abbar, C Gay, JA Meynard, F Baylé, ...
L'encephale 36, S86-102, 2010
272010
The system can't perform the operation now. Try again later.
Articles 1–20